U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    TRIM32 tripartite motif containing 32 [ Homo sapiens (human) ]

    Gene ID: 22954, updated on 10-Dec-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Degradation of TRIM32 is induced by RTA for Kaposi's sarcoma-associated herpesvirus lytic replication.

    Degradation of TRIM32 is induced by RTA for Kaposi's sarcoma-associated herpesvirus lytic replication.
    Zhang Y, Dong Z, Gu F, Xu Y, Li Y, Sun W, Rao W, Du S, Zhu C, Wang Y, Wei F, Cai Q., Free PMC Article

    07/18/2024
    CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer.

    CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer.
    Tang J, Li J, Lian J, Huang Y, Zhang Y, Lu Y, Zhong G, Wang Y, Zhang Z, Bai X, Fang M, Wu L, Shen H, Wu J, Wang Y, Zhang L, Zhang H., Free PMC Article

    07/11/2024
    Enhanced translocation of TRIM32 to mitochondria sensitizes dopaminergic neuronal cells to apoptosis during stress conditions in Parkinson's disease.

    Enhanced translocation of TRIM32 to mitochondria sensitizes dopaminergic neuronal cells to apoptosis during stress conditions in Parkinson's disease.
    Goyani S, Shinde A, Shukla S, Saranga MV, Currim F, Mane M, Singh J, Roy M, Gohel D, Chandak N, Vasiyani H, Singh R.

    06/25/2024
    Adipose stem cell-derived exosomes promote high glucose-induced wound healing by regulating the TRIM32/STING axis.

    Adipose stem cell‑derived exosomes promote high glucose-induced wound healing by regulating the TRIM32/STING axis.
    He L, Cai Y, Du H, Shu M, Zhu C.

    06/7/2024
    RHBDF1 deficiency suppresses melanoma glycolysis and enhances efficacy of immunotherapy by facilitating glucose-6-phosphate isomerase degradation via TRIM32.

    RHBDF1 deficiency suppresses melanoma glycolysis and enhances efficacy of immunotherapy by facilitating glucose-6-phosphate isomerase degradation via TRIM32.
    Wang L, Song YY, Wang Y, Liu XX, Yin YL, Gao S, Zhang F, Li LY, Zhang ZS.

    12/6/2023
    TRIM32 promotes oral squamous cell carcinoma progression by enhancing FBP2 ubiquitination and degradation.

    TRIM32 promotes oral squamous cell carcinoma progression by enhancing FBP2 ubiquitination and degradation.
    Yang X, Ma H, Zhang M, Wang R, Li X.

    09/19/2023
    Tripartite Motif-Containing Protein 32 (TRIM32): What Does It Do for Skeletal Muscle?

    Tripartite Motif-Containing Protein 32 (TRIM32): What Does It Do for Skeletal Muscle?
    Jeong SY, Choi JH, Kim J, Woo JS, Lee EH., Free PMC Article

    08/28/2023
    Overexpression of TRIM32 promotes pancreatic beta-cell autophagic cell death through Akt/mTOR pathway under high glucose conditions.

    Overexpression of TRIM32 promotes pancreatic β-cell autophagic cell death through Akt/mTOR pathway under high glucose conditions.
    Wan T, Wang Y, Wang C, Wang H, Li X, Li Y.

    11/29/2022
    TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3beta/Nrf2 Pathway.

    TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway.
    Chen Z, Tian L, Wang L, Ma X, Lei F, Chen X, Fu R.

    05/21/2022
    TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.

    TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.
    Ma Y, Zhang H, Chen C, Liu L, Ding T, Wang Y, Ma D, Ling X, Chen X, Li J, Guansheng, Zhong, Ru G, Zhang L, Tang J.

    04/30/2022
    TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K/Akt pathway in pulmonary arterial hypertension.

    TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K/Akt pathway in pulmonary arterial hypertension.
    Hu Z, Song Q, Ma H, Guo Y, Zhang T, Xie H, Luo X.

    02/5/2022
    TRIM32 regulates mitochondrial mediated ROS levels and sensitizes the oxidative stress induced cell death.

    TRIM32 regulates mitochondrial mediated ROS levels and sensitizes the oxidative stress induced cell death.
    Prajapati P, Gohel D, Shinde A, Roy M, Singh K, Singh R.

    12/4/2021
    Absence of TRIM32 Leads to Reduced GABAergic Interneuron Generation and Autism-like Behaviors in Mice via Suppressing mTOR Signaling.

    Absence of TRIM32 Leads to Reduced GABAergic Interneuron Generation and Autism-like Behaviors in Mice via Suppressing mTOR Signaling.
    Zhu JW, Zou MM, Li YF, Chen WJ, Liu JC, Chen H, Fang LP, Zhang Y, Wang ZT, Chen JB, Huang W, Li S, Jia WQ, Wang QQ, Zhen XC, Liu CF, Li S, Xiao ZC, Xu GQ, Schwamborn JC, Schachner M, Ma QH, Xu RX.

    11/22/2021
    Generation of the short TRIM32 isoform is regulated by Lys 247 acetylation and a PEST sequence.

    Generation of the short TRIM32 isoform is regulated by Lys 247 acetylation and a PEST sequence.
    Garcia-Garcia J, Overå KS, Khan W, Sjøttem E., Free PMC Article

    10/16/2021
    Deletion of HNF1A-AS1 Suppresses the Malignant Phenotypes of Breast Cancer Cells In Vitro and In Vivo Through Targeting miRNA-20a-5p/TRIM32 Axis.

    Deletion of HNF1A-AS1 Suppresses the Malignant Phenotypes of Breast Cancer Cells In Vitro and In Vivo Through Targeting miRNA-20a-5p/TRIM32 Axis.
    Meng Q, Wang L, Lv Y, Wu J, Shi W.

    10/9/2021
    Costameric integrin and sarcoglycan protein levels are altered in a Drosophila model for Limb-girdle muscular dystrophy type 2H.

    Costameric integrin and sarcoglycan protein levels are altered in a Drosophila model for Limb-girdle muscular dystrophy type 2H.
    Bawa S, Gameros S, Baumann K, Brooks DS, Kollhoff JA, Zolkiewski M, Re Cecconi AD, Panini N, Russo M, Piccirillo R, Johnson DK, Kashipathy MM, Battaile KP, Lovell S, Bouyain SEA, Kawakami J, Geisbrecht ER., Free PMC Article

    08/21/2021
    Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner.

    Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner.
    Cai Y, Gu WT, Cheng K, Jia PF, Li F, Wang M, Zhang WF, Qiu JT, Wu ZB, Zhao WG.

    06/26/2021
    TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.

    TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
    Luo Q, Wu X, Nan Y, Chang W, Zhao P, Zhang Y, Su D, Liu Z.

    01/9/2021
    TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.

    TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.
    Wang J, Fang Y, Liu T., Free PMC Article

    11/21/2020
    A TRIM32(LGMD2H) disease mutant was unable to undergo autophagic degradation and to mono-ubiquitylate p62, and its reintroduction into the TRIM32-knockout cells did not affect p62 dot formation.

    TRIM32, but not its muscular dystrophy-associated mutant, positively regulates and is targeted to autophagic degradation by p62/SQSTM1.
    Overå KS, Garcia-Garcia J, Bhujabal Z, Jain A, Øvervatn A, Larsen KB, Deretic V, Johansen T, Lamark T, Sjøttem E., Free PMC Article

    07/25/2020
    TRIM32 may regulate lung cancer cell proliferation, apoptosis, and motility.

    Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
    Yin H, Li Z, Chen J, Hu X.

    07/11/2020
    this study shows that TRIM32 promotes inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes

    TRIM32 promotes inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes.
    Liang T, Song M, Xu K, Guo C, Xu H, Zhang H, Xu L.

    06/13/2020
    A mutation in TRIM32 causes muscle dystrophy and reduced levels of TRIM32 was observed in all patient muscle studied.

    Altered myogenesis and premature senescence underlie human TRIM32-related myopathy.
    Servián-Morilla E, Cabrera-Serrano M, Rivas-Infante E, Carvajal A, Lamont PJ, Pelayo-Negro AL, Ravenscroft G, Junckerstorff R, Dyke JM, Fletcher S, Adams AM, Mavillard F, Fernández-García MA, Nieto-González JL, Laing NG, Paradas C., Free PMC Article

    04/4/2020
    In a cohort of non-Hutterite TRIM32 myopathy patients, several pathogenic variants are identified.

    Extending the clinical and mutational spectrum of TRIM32-related myopathies in a non-Hutterite population.
    Johnson K, De Ridder W, Töpf A, Bertoli M, Phillips L, De Jonghe P, Baets J, Deconinck T, Rakocevic Stojanovic V, Perić S, Durmus H, Jamal-Omidi S, Nafissi S, Mongini T, Łusakowska A, Busby M, Miller J, Norwood F, Hudson J, Barresi R, Lek M, MacArthur DG, Straub V., Free PMC Article

    12/14/2019
    the RING domain of TRIM32 protein is crucial for E3 ligase activity and E2 specificity, whereas a complete B-box domain is involved in chain assembly rate modulation.

    Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H.
    Lazzari E, El-Halawany MS, De March M, Valentino F, Cantatore F, Migliore C, Onesti S, Meroni G., Free PMC Article

    12/7/2019
    firstprevious page of 3 nextlast